Eptifibatide
Product Images NDC 25021-409

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 25021-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ept01 0005 01)

Structural Formula (Ept01 0005 01)
Chemical structure of eptifibatide, displaying its complex peptide molecular arrangement with various functional groups and ring structures as represented in the diagram.*
FDA Label Image

Figure 1 (Ept01 0005 02)

Figure 1 (Ept01 0005 02)
A line chart comparing the percent of patients with events over 30 days for eptifibatide and placebo treatments. The x-axis represents time in days (0 to 30), and the y-axis shows the percent of patients with events (0 to 16%). Two lines are displayed: a solid line for eptifibatide and a dashed line for placebo, with placebo showing a higher event rate over time.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0005 03)

Package Label – Principal Display Panel – Vial Label (Ept01 0005 03)
Eptifibatide injection label showing strength of 75 mg per 100 mL (0.75 mg per mL) in a 100 mL single-dose vial. The label states it is for intravenous use only, preservative-free, and nonpyrogenic. It is manufactured by Sagent Pharmaceuticals. The label includes storage instructions, lot, and expiration date fields.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0005 04)

Package Label – Principal Display Panel – Vial Label (Ept01 0005 04)
Packaging label for eptifibatide injection, 20 mg per 10 mL (2 mg per mL) single-use vial. The label indicates intravenous use only and is from Sagent Pharmaceuticals. Additional details include storage instructions and sterility information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.